Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study.
Montella L, Dell'Aversana C, Pacella D, Troise S, Russo P, Cacciapuoti V, Ottaiano A, Di Marino L, Coppola P, Liguori C, Berretta M, Maddaluno S, Altucci L, Facchini G. Montella L, et al. Among authors: ottaiano a. Infect Agent Cancer. 2023 Oct 17;18(1):62. doi: 10.1186/s13027-023-00532-9. Infect Agent Cancer. 2023. PMID: 37848958 Free PMC article.
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
Facchini G, Caraglia M, Santini D, Nasti G, Ottaiano A, Striano S, Maiolino P, Ruberto M, Fiore F, Tonini G, Budillon A, Iaffaioli RV, Zeppetella GL. Facchini G, et al. Among authors: ottaiano a. J Exp Clin Cancer Res. 2007 Sep;26(3):307-12. J Exp Clin Cancer Res. 2007. PMID: 17987788 Clinical Trial.
Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?
Silvestro L, Nasti G, Ottaiano A, Montano M, Casaretti R, Avallone A, Berretta M, Romano C, Cassata A, Tafuto S, Iaffaioli RV. Silvestro L, et al. Among authors: ottaiano a. Anticancer Agents Med Chem. 2013 Nov;13(9):1364-70. doi: 10.2174/18715206113136660356. Anticancer Agents Med Chem. 2013. PMID: 24102272 Review.
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).
Esposito F, Cecere SC, Magazzino F, Katsaros D, Ottaiano A, Gadducci A, Pisano C, Scalone S, Rabaiotti E, Salutari V, Cormio G, Canuto EM, Greggi S, Savarese A, Marinaccio M, Scollo P, Santeufemia DA, Sacco C, Facchini G, Pignata S. Esposito F, et al. Among authors: ottaiano a. Oncology. 2014;86(5-6):351-8. doi: 10.1159/000358730. Epub 2014 Jun 12. Oncology. 2014. PMID: 24942520
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.
Ottaiano A, De Stefano A, Capozzi M, Nappi A, De Divitiis C, Romano C, Silvestro L, Cassata A, Casaretti R, Tafuto S, Caraglia M, Berretta M, Nasti G, Avallone A. Ottaiano A, et al. Front Pharmacol. 2018 May 3;9:441. doi: 10.3389/fphar.2018.00441. eCollection 2018. Front Pharmacol. 2018. PMID: 29773991 Free PMC article. Review.
Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors.
Ottaiano A, Scotti V, De Divitiis C, Capozzi M, Romano C, Cassata A, Casaretti R, Silvestro L, Nappi A, Vicario V, De Stefano A, Tafuto S, Berretta M, Nasti G, Avallone A. Ottaiano A, et al. Oncotarget. 2018 Oct 16;9(81):35251-35265. doi: 10.18632/oncotarget.25834. eCollection 2018 Oct 16. Oncotarget. 2018. PMID: 30443292 Free PMC article.
212 results